SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-137890"
 

Search: onr:"swepub:oai:DiVA.org:umu-137890" > Metastatic spinal c...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Wänman, JohanUmeå universitet,Ortopedi (author)

Metastatic spinal cord compression as the first sign of malignancy : Outcome after surgery in 69 patients

  • Article/chapterEnglish2017

Publisher, publication year, extent ...

  • 2017-05-11
  • Taylor & Francis,2017
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-137890
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-137890URI
  • https://doi.org/10.1080/17453674.2017.1319179DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background and purpose - Metastatic spinal cord compression (MSCC) as the initial manifestation of malignancy (IMM) limits the time for diagnostic workup; most often, treatment is required before the final primary tumor diagnosis. We evaluated neurological outcome, complications, survival, and the manner of diagnosing the primary tumor in patients who were operated for MSCC as the IMM.Patients and methods - Records of 69 consecutive patients (51 men) who underwent surgery for MSCC as the IMM were reviewed. The patients had no history of cancer when they presented with pain (n = 2) and/or neurological symptoms (n = 67).Results - The primary tumor was identified in 59 patients. In 10 patients, no specific diagnosis could be established, and they were therefore defined as having cancer of unknown primary tumor (CUP). At the end of the study, 16 patients were still alive (median follow-up 2.5 years). The overall survival time was 20 months. Patients with CUP had the shortest survival (3.5 months) whereas patients with prostate cancer (6 years) and myeloma (5 years) had the longest survival. 20 of the 39 patients who were non-ambulatory preoperatively regained walking ability, and 29 of the 30 ambulatory patients preoperatively retained their walking ability 1 month postoperatively. 15 of the 69 patients suffered from a total of 20 complications within 1 month postoperatively.Interpretation - Postoperative survival with MSCC as the IMM depends on the type of primary tumor. Surgery in these patients maintains and improves ambulatory function.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Grabowski, PawelUmeå universitet,Ortopedi(Swepub:umu)palgri99 (author)
  • Nyström, HelenaUmeå universitet,Geriatrik(Swepub:umu)hegu0003 (author)
  • Gustafsson, PatrikUmeå universitet,Ortopedi(Swepub:umu)pakgon02 (author)
  • Bergh, AndersUmeå universitet,Patologi(Swepub:umu)anbe0010 (author)
  • Widmark, AndersUmeå universitet,Onkologi(Swepub:umu)anwi0004 (author)
  • Crnalic, SeadUmeå universitet,Ortopedi(Swepub:umu)secr0001 (author)
  • Umeå universitetOrtopedi (creator_code:org_t)

Related titles

  • In:Acta Orthopaedica: Taylor & Francis88:4, s. 457-4621745-36741745-3682

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view